169 related articles for article (PubMed ID: 15726649)
21. Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication.
Zheng YH; Irwin D; Kurosu T; Tokunaga K; Sata T; Peterlin BM
J Virol; 2004 Jun; 78(11):6073-6. PubMed ID: 15141007
[TBL] [Abstract][Full Text] [Related]
22. The potential role of APOBEC3G in limiting replication of hepatitis B virus.
Mohamadkhani A; Pourdadash A; Tayebi S; Estakhri A; Nazem H; Sotoudeh M; Poustchi H
Arab J Gastroenterol; 2012 Dec; 13(4):170-3. PubMed ID: 23432984
[TBL] [Abstract][Full Text] [Related]
23. Comment on "Inhibition of hepatitis B virus replication by APOBEC3G".
Rösler C; Köck J; Malim MH; Blum HE; von Weizsäcker F
Science; 2004 Sep; 305(5689):1403; author reply 1403. PubMed ID: 15353783
[No Abstract] [Full Text] [Related]
24. Anti-viral protein APOBEC3G is induced by interferon-alpha stimulation in human hepatocytes.
Tanaka Y; Marusawa H; Seno H; Matsumoto Y; Ueda Y; Kodama Y; Endo Y; Yamauchi J; Matsumoto T; Takaori-Kondo A; Ikai I; Chiba T
Biochem Biophys Res Commun; 2006 Mar; 341(2):314-9. PubMed ID: 16426578
[TBL] [Abstract][Full Text] [Related]
25. Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome.
Yu Q; König R; Pillai S; Chiles K; Kearney M; Palmer S; Richman D; Coffin JM; Landau NR
Nat Struct Mol Biol; 2004 May; 11(5):435-42. PubMed ID: 15098018
[TBL] [Abstract][Full Text] [Related]
26. Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication.
Bonvin M; Achermann F; Greeve I; Stroka D; Keogh A; Inderbitzin D; Candinas D; Sommer P; Wain-Hobson S; Vartanian JP; Greeve J
Hepatology; 2006 Jun; 43(6):1364-74. PubMed ID: 16729314
[TBL] [Abstract][Full Text] [Related]
27. [Inhibitory effect of a HBV vector plasmid expressing A3C on HBV replication].
Li D; Wang YM
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Oct; 29(10):2044-7, 2050. PubMed ID: 19861262
[TBL] [Abstract][Full Text] [Related]
28. Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells.
Chiu YL; Soros VB; Kreisberg JF; Stopak K; Yonemoto W; Greene WC
Nature; 2005 May; 435(7038):108-14. PubMed ID: 15829920
[TBL] [Abstract][Full Text] [Related]
29. Restriction of foamy viruses by APOBEC cytidine deaminases.
Delebecque F; Suspène R; Calattini S; Casartelli N; Saïb A; Froment A; Wain-Hobson S; Gessain A; Vartanian JP; Schwartz O
J Virol; 2006 Jan; 80(2):605-14. PubMed ID: 16378963
[TBL] [Abstract][Full Text] [Related]
30. APOBEC family proteins: novel antiviral innate immunity.
Takaori-Kondo A
Int J Hematol; 2006 Apr; 83(3):213-6. PubMed ID: 16720550
[TBL] [Abstract][Full Text] [Related]
31. Full genome ultra-deep pyrosequencing associates G-to-A hypermutation of the hepatitis B virus genome with the natural progression of hepatitis B.
Beggel B; Münk C; Däumer M; Hauck K; Häussinger D; Lengauer T; Erhardt A
J Viral Hepat; 2013 Dec; 20(12):882-9. PubMed ID: 24304458
[TBL] [Abstract][Full Text] [Related]
32. APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase.
Suspène R; Sommer P; Henry M; Ferris S; Guétard D; Pochet S; Chester A; Navaratnam N; Wain-Hobson S; Vartanian JP
Nucleic Acids Res; 2004; 32(8):2421-9. PubMed ID: 15121899
[TBL] [Abstract][Full Text] [Related]
33. Extensive editing of a small fraction of human T-cell leukemia virus type 1 genomes by four APOBEC3 cytidine deaminases.
Mahieux R; Suspène R; Delebecque F; Henry M; Schwartz O; Wain-Hobson S; Vartanian JP
J Gen Virol; 2005 Sep; 86(Pt 9):2489-2494. PubMed ID: 16099907
[TBL] [Abstract][Full Text] [Related]
34. Polymorphic APOBEC3 modulates chronic hepatitis B in Moroccan population.
Ezzikouri S; Kitab B; Rebbani K; Marchio A; Wain-Hobson S; Dejean A; Vartanian JP; Pineau P; Benjelloun S
J Viral Hepat; 2013 Oct; 20(10):678-86. PubMed ID: 24010642
[TBL] [Abstract][Full Text] [Related]
35. Conserved footprints of APOBEC3G on Hypermutated human immunodeficiency virus type 1 and human endogenous retrovirus HERV-K(HML2) sequences.
Armitage AE; Katzourakis A; de Oliveira T; Welch JJ; Belshaw R; Bishop KN; Kramer B; McMichael AJ; Rambaut A; Iversen AK
J Virol; 2008 Sep; 82(17):8743-61. PubMed ID: 18562517
[TBL] [Abstract][Full Text] [Related]
36. High expression of APOBEC3G in patients infected with hepatitis C virus.
Komohara Y; Yano H; Shichijo S; Shimotohno K; Itoh K; Yamada A
J Mol Histol; 2006 Nov; 37(8-9):327-32. PubMed ID: 17036163
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis B: modern concepts in pathogenesis--APOBEC3 cytidine deaminases as effectors in innate immunity against the hepatitis B virus.
Bonvin M; Greeve J
Curr Opin Infect Dis; 2008 Jun; 21(3):298-303. PubMed ID: 18448976
[TBL] [Abstract][Full Text] [Related]
38. Compound IMB-Z inhibits hepatitis B virus replication through increasing APOBEC3G expression and incorporation into viral nucleocapsids.
Hu J; Wang H; Yang L; Wu S; Li Y; Li Y; Li Z
J Glob Antimicrob Resist; 2022 Dec; 31():371-378. PubMed ID: 36396043
[TBL] [Abstract][Full Text] [Related]
39. Different antiviral activities of natural APOBEC3C, APOBEC3G, and APOBEC3H variants against hepatitis B virus.
Kanagaraj A; Sakamoto N; Que L; Li Y; Mohiuddin M; Koura M; Wakae K; Kurachi M; Muramatsu M; Kitamura K
Biochem Biophys Res Commun; 2019 Oct; 518(1):26-31. PubMed ID: 31400856
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-1 and tumor necrosis factor-α trigger restriction of hepatitis B virus infection via a cytidine deaminase activation-induced cytidine deaminase (AID).
Watashi K; Liang G; Iwamoto M; Marusawa H; Uchida N; Daito T; Kitamura K; Muramatsu M; Ohashi H; Kiyohara T; Suzuki R; Li J; Tong S; Tanaka Y; Murata K; Aizaki H; Wakita T
J Biol Chem; 2013 Nov; 288(44):31715-27. PubMed ID: 24025329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
